Adaptive Biotechnologies stockADPT
Adaptive Biotechnologies trades at $26.83, 12.7% below its 52-week high (Oct 6, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +65.2% year to date, +52.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 16, 2027.
Ratings, candles, signals and the screener for ADPT — after you log in
Open the terminalFrequently asked questions about Adaptive Biotechnologies
What is the Adaptive Biotechnologies stock price?
At the close on Nov 5, 2026: $26.83 (+0.45% on the day). 52-week high: $30.74 on Oct 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Adaptive Biotechnologies report earnings?
The next quarterly report is on Feb 16, 2027. Last quarter, earnings per share changed −67% year over year, revenue −11%.
Does Adaptive Biotechnologies pay dividends?
No, Adaptive Biotechnologies does not pay dividends.
Where does Adaptive Biotechnologies trade and how to buy it?
Ticker ADPT, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Adaptive Biotechnologies now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ADPT are in the terminal after you log in.